About the Authors
- Lei Ding
-
¶LD and CAG are shared first authors on this work.
Affiliation Laboratory of Clinical and Experimental Endocrinology, Campus Gasthuisberg O&N1, Faculty of Medicine, Katholieke Universiteit Leuven (KU LEUVEN), Leuven, Belgium
- Conny A. Gysemans
-
* E-mail: Conny.Gysemans@med.kuleuven.be (CAG); chantal.mathieu@med.kuleuven.be (CM)
¶LD and CAG are shared first authors on this work.
Affiliation Laboratory of Clinical and Experimental Endocrinology, Campus Gasthuisberg O&N1, Faculty of Medicine, Katholieke Universiteit Leuven (KU LEUVEN), Leuven, Belgium
- Geert Stangé
-
Affiliation Laboratory of Diabetes Pathology and Therapy, Diabetes Research Center, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB), Brussels, Belgium
- Yves Heremans
-
Affiliation Laboratory of Beta Cell Neogenesis (BENE), Diabetes Research Center, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB), Brussels, Belgium
- Yixing Yuchi
-
Affiliation Laboratory of Beta Cell Neogenesis (BENE), Diabetes Research Center, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB), Brussels, Belgium
- Tatiana Takiishi
-
Affiliation Laboratory of Clinical and Experimental Endocrinology, Campus Gasthuisberg O&N1, Faculty of Medicine, Katholieke Universiteit Leuven (KU LEUVEN), Leuven, Belgium
- Hannelie Korf
-
Affiliation Laboratory of Clinical and Experimental Endocrinology, Campus Gasthuisberg O&N1, Faculty of Medicine, Katholieke Universiteit Leuven (KU LEUVEN), Leuven, Belgium
- Marie Chintinne
-
Affiliation Laboratory of Diabetes Pathology and Therapy, Diabetes Research Center, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB), Brussels, Belgium
- Richard D. Carr
-
Affiliation MSD A/S, Ballerup, Denmark
- Harry Heimberg
-
Affiliation Laboratory of Beta Cell Neogenesis (BENE), Diabetes Research Center, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB), Brussels, Belgium
- Daniel Pipeleers
-
Affiliation Laboratory of Diabetes Pathology and Therapy, Diabetes Research Center, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB), Brussels, Belgium
- Chantal Mathieu
-
* E-mail: Conny.Gysemans@med.kuleuven.be (CAG); chantal.mathieu@med.kuleuven.be (CM)
Affiliation Laboratory of Clinical and Experimental Endocrinology, Campus Gasthuisberg O&N1, Faculty of Medicine, Katholieke Universiteit Leuven (KU LEUVEN), Leuven, Belgium
Competing Interests
Richard D. Carr owns shares in Merck Inc., (known as MSD in Europe). This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: LD GS YH YY MC HK TT CAG DP CM. Performed the experiments: LD GS YH YY MC HK TT CAG. Analyzed the data: LD GS DP CAG CM. Contributed reagents/materials/analysis tools: RDC. Wrote the paper: LD YH RDC DP HH CAG CM. Revised the manuscript critically for important intellectual content: CAG CM. Guarantors of this work: LD CAG CM. Had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis: LD CAG CM.